Skip to main content
Pharmaceutical API Purification
Process Purification & Recovery

Pharmaceutical API Purification

USP and EP grade powdered activated carbon for active pharmaceutical ingredient (API) purification by slurry contact, removing colour bodies, residual catalysts, and trace impurities ahead of final crystallisation.

The Challenge
API synthesis generates colour bodies (from thermal stress, oxidation, and side reactions), residual metal catalysts (palladium, platinum, rhodium), and trace organic impurities that must be removed before the final crystallisation to meet the API specification. PAC slurry treatment is the standard purification route.
Quick Answer

Pharmaceutical API purification uses USP and EP grade powdered activated carbon dosed into the contact reactor to remove colour bodies, residual catalysts, and trace impurities from active pharmaceutical ingredient process streams. Carbon is filtered out with a sterile or guard filter ahead of final crystallisation. Change control documentation supports the GMP regime.

Pharmaceutical API Purification

API Purification Is GMP Critical

Active pharmaceutical ingredient (API) production requires the most demanding purification regime of any SorbiTech application. The final API must meet the product monograph specification on colour, residual solvent, residual catalyst, related substances, and impurity profile. PAC slurry treatment at the late stage of synthesis is the standard purification route, removing the colour bodies, residual transition metal catalysts, and trace organic impurities that the upstream synthesis steps did not address.

USP and EP Grade PAC Specification

The carbon must meet the USP or EP monograph for activated carbon: heavy metals below the regulated limits, ash below 6 percent, moisture below 10 percent, and the decolorization performance against the standard reference. SorbiTech USP/EP grade PAC meets these limits with full COA per lot and the change control documentation that the GMP regime requires.

Pharmaceutical API Purification process equipment

Process Integration

The PAC is dosed into the contact reactor at the contracted stage of the synthesis (typically just before the final crystallisation). The slurry is mixed at the working temperature for the contracted residence time (typically 30 to 60 minutes), then filtered through a 0.2 micron sterile filter or a guard filter ahead of the next process step. The spent carbon is collected with the filter cake and disposed of as pharmaceutical waste under the regional regulation.

Documentation and Change Control

Every shipment carries the certificate of analysis, the material safety data sheet, the traceability from raw material lot, and the change control notifications for any specification or process modification. The SorbiTech manufacturing facility supports FDA and EMA audits with the operator at the manufacturing site on request. Sector coverage is pharmaceutical and life sciences.

Selection Guidance

USP/EP grade PAC at 0.2 to 1 percent dose. Laboratory decolorization and impurity removal test against the actual API stream. Sterile or guard filter downstream. Full change control documentation.

A Specified, Verified Solution

Define the duty

We capture your process conditions: flow, composition, pressure, temperature, and the target outlet specification.

Select media & configuration

Our engineers recommend the adsorbent grade and system type that meet the duty with margin.

Size & engineer

Bed sizing, vessel design, and cycle parameters are engineered to your case and documented for approval.

Commission & verify

We support loading, start up, and performance verification against the guarantee.

Specify a Solution for This Application

Provide your process conditions and our team will recommend the grade, configuration, and sizing.